Further funding will accelerate the Royal Navy’s shift to uncrewed rotary‑wing operations and open export avenues for British defence technology. The programme’s success signals growing demand for autonomous maritime solutions worldwide.
Autonomous systems are reshaping modern militaries, and the United Kingdom has placed uncrewed aerial technology at the core of its defence modernization agenda. Leonardo UK, a long‑standing aerospace and security contractor, leverages its Yeovil facility to develop the Proteus rotary‑wing uncrewed air system, a platform designed to operate alongside manned assets and reduce risk in contested environments. The programme aligns with the Ministry of Defence’s push for modular, AI‑driven solutions that can be rapidly fielded across land, sea and air domains, reinforcing the UK’s strategic autonomy.
The Proteus demonstrator achieved its maiden flight in January 2026, showcasing a suite of capabilities including autonomous take‑off, precision navigation and payload flexibility. Funded initially by a £60 million four‑year MoD contract awarded in 2022, the Phase 3A technology demonstrator serves as a testbed for advanced sensors, swarming algorithms and secure data links. Successful trials have validated the system’s suitability for Royal Navy operations, where uncrewed rotary‑wing platforms can extend surveillance ranges, support anti‑submarine warfare and provide rapid response without endangering crew.
With the UK’s Defence Investment Plan on the horizon, Leonardo is positioning Proteus for additional funding and export opportunities. Early interest from NATO allies and other international customers signals a growing market for maritime‑focused uncrewed solutions, especially as navies worldwide seek to augment legacy fleets with cost‑effective autonomy. If the programme secures the anticipated follow‑on investment, it could catalyse a new generation of British‑made UAVs, stimulate supply‑chain growth and reinforce the UK’s reputation as a hub for cutting‑edge defence technology.
Comments
Want to join the conversation?
Loading comments...